Sign in to follow
Search Results

0 results for 'eric payne'

You can use to get even better search results
September 03, 2015 | Insurance Coverage Law Center

Hartford Cas. Ins. Co. v. J.R. Mktg., L.L.C.

Click Here for FC&S Legal Expert Analysis  Hartford Cas. Ins. Co.v.J.R. Mktg., L.L.C. 61 Cal.4th 988Supreme Court of CaliforniaHARTFORD…
52 minute read
August 11, 2015 |

Burger King: One Direction, Buzzfeed Spurred Chicken Fries

Fans of Burger King's chicken fries may have the boy band One Direction and the website Buzzfeed to thank for the return of the skinny fried sticks.
2 minute read
August 11, 2015 | Law.com

Burger King: One Direction, Buzzfeed Spurred Chicken Fries

Fans of Burger King's chicken fries may have the boy band One Direction and the website Buzzfeed to thank for the return of the skinny fried sticks.
2 minute read
August 06, 2015 |

Big Deals: Pharma Company Buys Generics Business for $40.5B

Israel's Teva Pharmaceutical Industries Ltd. is purchasing Dublin-based Allergan PLC's generic pharmaceuticals business for $40.5 billion, in what Israeli analysts called the largest-ever acquisition by an Israeli company.
3 minute read
August 05, 2015 | Law.com

Big Deals: Pharma Company Buys Generics Business for $40.5B

Israel's Teva Pharmaceutical Industries Ltd. is purchasing Dublin-based Allergan PLC's generic pharmaceuticals business for $40.5 billion, in what Israeli analysts called the largest-ever acquisition by an Israeli company.
3 minute read
July 31, 2015 |

Dealmaker of the Week: Joseph Frumkin of Sullivan & Cromwell

The managing partner of Sullivan & Cromwell's M&A group stepped in for Kirkland & Ellis on Teva Pharmaceutical Industries' hostile bid for Mylan and subsequently picked up work on the Israeli drugmaker's $40.5 billion buy of Allergan's generics business.
6 minute read
July 31, 2015 | Law.com

Dealmaker of the Week: Joseph Frumkin of Sullivan & Cromwell

The managing partner of Sullivan & Cromwell's M&A group stepped in for Kirkland & Ellis on Teva Pharmaceutical Industries' hostile bid for Mylan and subsequently picked up work on the Israeli drugmaker's $40.5 billion buy of Allergan's generics business.
6 minute read
July 30, 2015 |

This Week's Deals

A round-up of transactions involving Bay Area lawyers and companies.
4 minute read
July 30, 2015 | Law.com

This Week's Deals

A round-up of transactions involving Bay Area lawyers and companies.
4 minute read
July 27, 2015 |

Another Big Deal in Frenzied Pharma Sector

Latham's Charles Ruck, who advised Allergan on the sale of its generics business for $40.5 billion, has been busy.
3 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • A Buyer's Guide to Law Firm Software

      Brought to you by PracticePanther

      Download Now

    • A Step-by-Step Flight Plan for Legal Teams: Fire Up Your Productivity Engine and Deliver High-Impact Work Faster

      Brought to you by HaystackID

      Download Now

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now